We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Fines AstraZeneca for Blocking Generic Competition for Losec
EU Fines AstraZeneca for Blocking Generic Competition for Losec
June 28, 2005
The European Union (EU) has fined AstraZeneca $73 million for artificially inflating the price of its ulcer treatment Losec and misusing the EU’s patent system to delay entry of generic competition for the drug.